As cases of the coronavirus continue to rise in the US and globally, there is increasing need to find more efficient ways to identify at-risk populations and find potential solutions to protect people from symptom onset. In a recent study, Nancy A Dreyer, chief scientific officer and senior vice president, Real World Solutions, IQVIA, identified factors that could imply COVID-19 positivity and help facilitate diagnosis and triage without testing, as well as better predict who is most at-risk of developing serious infections.
As an epidemiologist, Ms. Dreyer, has history working with infectious diseases—COVID-19 is her third pandemic. She began her work with H5N1 influenza A, commonly known as the avian flu, which was highly lethal with a case-fatality rate of close to 90%—with a median of 9 days from first symptom to death. “I helped create the world’s largest patient registry by reviewing hospital records from bird flu cases throughout southeast Asia,” she explained. “We discovered that a medication that was approved for seasonal influenza quadrupled the likelihood of surviving avian influenza, a very exciting finding. Later I worked H1N1 influenza by studying vaccine safety.”
Find out more about Ms. Dreyer’s recent work on COVID here.